Upon adoptive transfer of ALDH1A1-specific CD8+ T cells into xenograft-bearing immunodeficient mice, ALDHbright cells were selectively eliminated, cancer growth and metastases were inhibited, and animals’ survival were prolonged (Visus et al., 2011). The gene discussed is CD8A; the disease is cancer.